The DOI matches its Crossref record; 200 of the 200 references it cites were found in a registry or an index.
The Many Faces of Tau
Open accessAbstract
While the microtubule-binding capacity of the protein tau has been known for many years, new functions of tau in signaling and cytoskeletal organization have recently emerged. In this review, we highlight these functions and the potential roles of tau in neurodegenerative disease. We also discuss the therapeutic potential of drugs targeting various aspects of tau biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“markedly reduces amyloid 𝛃 and ApoE4 fragment-induced neuronal and cognitive impairments in vivo (34)”
From An Unbiased Approach to Identifying Tau Kinases That Phosphorylate Tau at Sites Associated with Alzheimer Disease (2013) · cites this paper as [34]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Reductions in tau levels have also been shown to prevent amyloid 𝛃 from causing neuronal deficits in cell culture and in transgenic mice expressing human amyloid precursor protein (34).”
From An Unbiased Approach to Identifying Tau Kinases That Phosphorylate Tau at Sites Associated with Alzheimer Disease (2013) · cites this paper as [34]
The cited source says what the claim attributes to it.
In the citing paper
“in mice a 50% reduction of endogenous tau is well tolerated”
From An Unbiased Approach to Identifying Tau Kinases That Phosphorylate Tau at Sites Associated with Alzheimer Disease (2013) · cites this paper as [34]
The cited source says what the claim attributes to it.
In the citing paper
“The interaction of tau with microtubules in neurons is well documented and more recent studies have proposed that tau also binds to actin34.”
From Tau co-organizes dynamic microtubule and actin networks (2015) · cites this paper as [34]
In the citing paper
“Tauopathies are neurodegenerative diseases characterized by aberrant forms of tau protein accumulation leading to neuronal death in focal brain areas.”
From Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models (2019) · cites this paper as Morris et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
A protein factor essential for microtubule assembly
Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.5.1858 · Cited by 3,089
Mechanisms and Functional Implications of Adult Neurogenesis
Zhao, C., Deng, W., & Gage, F. H. (2008) · Cell · doi:10.1016/j.cell.2008.01.033 · Cited by 3,007
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function
SantaCruz, K., Lewis, J., Spires, T., Paulson, J., Kotilinek, L., Ingelsson, M., Guimaraes, A., DeTure, M., Ramsden, M., McGowan, E., et al. (2005) · Science · doi:10.1126/science.1113694 · Cited by 2,014
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892
Self-citationDendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., Wölfing, H., Chieng, B. C., Christie, M. J., Napier, I. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.036 · Cited by 1,821
Transmission and spreading of tauopathy in transgenic mouse brain
Clavaguera, F., Bolmont, T., Crowther, R. A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A. K., Beibel, M., Staufenbiel, M., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1901 · Cited by 1,803
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 900
George, E., & Reddy, P. H. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190232 · Cited by 55
Tau is not necessary for amyloid-β–induced synaptic and memory impairments
Puzzo, D., Argyrousi, E. K., Staniszewski, A., Zhang, H., Calcagno, E., Zuccarello, E., Acquarone, E., Fà, M., Puma, D. D. L., Grassi, C., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137040 · Cited by 53
Zhang, Z.-H., Wen, L., Wu, Q., Chen, C., Zheng, R., Liu, Q., Ni, J., & Song, G.-L. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b01465 · Cited by 52
Noradrenaline in the aging brain: Promoting cognitive reserve or accelerating Alzheimer's disease?
Mather, M. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.05.013 · Cited by 57
Silva, M. C., Nandi, G., Donovan, K. A., Cai, Q., Berry, B. C., Nowak, R. P., Fischer, E. S., Gray, N. S., Ferguson, F. M., & Haggarty, S. J. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.801179 · Cited by 51
Tau secretion is correlated to an increase of Golgi dynamics
Mohamed, N., Desjardins, A., & Leclerc, N. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178288 · Cited by 55
Takeda, S. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01274 · Cited by 53
Webber, E. K., Fivaz, M., Stutzmann, G. E., & Griffioen, G. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13065 · Cited by 50
Rossi, G., Conconi, D., Panzeri, E., Redaelli, S., Piccoli, E., Paoletta, L., Dalprà, L., & Tagliavini, F. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121633 · Cited by 61
Huang, C., Chu, J., Liu, Y., Chang, R. C., & Wong, G. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.09.044 · Cited by 44
Tau and neurofilament light‐chain as fluid biomarkers in spinocerebellar ataxia type 3
Garcia‐Moreno, H., Prudencio, M., Thomas‐Black, G., Solanky, N., Jansen‐West, K. R., Hanna AL‐Shaikh, R., Heslegrave, A., Zetterberg, H., Santana, M. M., Pereira de Almeida, L., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15373 · Cited by 49
Schroeder, S. K., Joly‐Amado, A., Gordon, M. N., & Morgan, D. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9637-6 · Cited by 51
Messing, L., Decker, J. M., Joseph, M., Mandelkow�, E., & Mandelkow, E.-M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.10.024 · Cited by 48
Chung, P. J., Choi, M. C., Miller, H. P., Feinstein, H. E., Raviv, U., Li, Y., Wilson, L., Feinstein, S. C., & Safinya, C. R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1513172112 · Cited by 49
Bossenmeyer‐Pourié, C., Smith, A. D., Lehmann, S., Deramecourt, V., Sablonnière, B., Camadro, J., Pourié, G., Kerek, R., Helle, D., Umoret, R., et al. (2019) · The Journal of Pathology · doi:10.1002/path.5254 · Cited by 49
Datta, D., Conroy, A. L., Castelluccio, P., Ssenkusu, J. M., Park, G. S., Opoka, R. O., Bangirana, P., Idro, R., Saykin, A. J., & John, C. C. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz325 · Cited by 49
A conceptual view at microtubule plus end dynamics in neuronal axons
Voelzmann, A., Hahn, I., Pearce, S. P., Sánchez‐Soriano, N., & Prokop, A. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.08.006 · Cited by 50
Reflections on the Utility of the Retina as a Biomarker for Alzheimer’s Disease: A Literature Review
Ngolab, J., Honma, P. S., & Rissman, R. A. (2019) · Neurology and Therapy · doi:10.1007/s40120-019-00173-4 · Cited by 50
Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease
Aillaud, I., & Funke, S. A. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01230-7 · Cited by 51
A Glimpse of Molecular Biomarkers in Huntington’s Disease
Martínez, S. M., & Valor, L. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105411 · Cited by 47
Hyperphosphorylated tau is implicated in acquired epilepsy and neuropsychiatric comorbidities.
Zheng, P., Shultz, S. R., Hovens, C. M., Velakoulis, D., Jones, N. C., & O’Brien, T. J. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8601-9 · Cited by 48
Violent Female Action Characters in Contemporary American Cinema
Gilpatric, K. (2010) · Sex Roles · doi:10.1007/s11199-010-9757-7 · Cited by 49
Davis, G. A., Castellani, R. J., & McCrory, P. (2015) · Neurosurgery · doi:10.1227/neu.0000000000000722 · Cited by 47
Mellone, M., Kestoras, D., Andrews, M. R., Dassie, E., Crowther, R. A., Stokin, G. B., Tinsley, J. M., Horne, G., Goedert, M., Tolkovsky, A. M., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4933-12.2013 · Cited by 44
NDP52 associates with phosphorylated tau in brains of an Alzheimer disease mouse model
Kim, S., Lee, D., Song, J. C., Cho, S., Yun, S., Koh, Y. H., Song, J., Johnson, G. V. W., & Jo, C. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.10.066 · Cited by 47
Biswal, S., Sharma, D., Kumar, K., Nag, T. C., Barhwal, K. K., Hota, S. K., & Kumar, B. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.05.011 · Cited by 47
Enhanced tau pathology via RanBP9 and Hsp90/Hsc70 chaperone complexes
Woo, J. A., Liu, T., Zhao, X., Trotter, C., Yrigoin, K., Cazzaro, S., Narvaez, E. D., Khan, H., Witas, R., Bukhari, A., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx284 · Cited by 46
Photoexcited Toluidine Blue Inhibits Tau Aggregation in Alzheimer’s Disease
Dubey, T., Gorantla, N. V., Chandrashekara, K. T., & Chinnathambi, S. (2019) · ACS Omega · doi:10.1021/acsomega.9b02792 · Cited by 47
Aβ and Tau Regulate Microglia Metabolism via Exosomes in Alzheimer’s Disease
Zhao, Y., Liu, B., Wang, J., Xu, L., Yu, S., Fu, J., Yan, X., & Su, J. (2022) · Biomedicines · doi:10.3390/biomedicines10081800 · Cited by 48
Longfield, S. F., Mollazade, M., Wallis, T. P., Gormal, R. S., Joensuu, M., Wark, J. R., Waardenberg, A. J., Small, C., Graham, M. E., Meunier, F. A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43130-4 · Cited by 47
Pathogenic and physiological autoantibodies in the central nervous system
Gold, M., Pul, R., Bach, J., Stangel, M., & Dodel, R. C. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01128.x · Cited by 47
Platt, T. L., Reeves, V. L., & Murphy, M. P. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.04.017 · Cited by 48
NMDA receptors and BAX are essential for Aβ impairment of LTP
Olsen, K. M., & Sheng, M. (2012) · Scientific Reports · doi:10.1038/srep00225 · Cited by 47
Tremblay, C., François, A., Delay, C., Freland, L., Vandal, M., Bennett, D. A., & Calon, F. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw109 · Cited by 49
Kim, J. H., Kim, E.-K., Choi, W. H., Lee, J., Lee, J. H., Lee, H., Kim, D., Suh, Y. H., & Lee, M. J. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00165 · Cited by 48
Bi, C., Bi, S., & Li, B. (2018) · Aging and Disease · doi:10.14336/ad.2018.0425 · Cited by 46
Developmental Expression of 4-Repeat-Tau Induces Neuronal Aneuploidy in Drosophila Tauopathy Models
Malmanche, N., Dourlen, P., Gistelinck, M., Demiautte, F., Link, N., Dupont, C., Broeck, L. V., Werkmeister, E., Amouyel, P., Bongiovanni, A., et al. (2017) · Scientific Reports · doi:10.1038/srep40764 · Cited by 48
Bullmann, T., Seeger, G., Stieler, J., Hanics, J., Reimann, K., Kretzschmann, T. P., Hilbrich, I., Holzer, M., Alpár, A., & Arendt, T. (2015) · Hippocampus · doi:10.1002/hipo.22522 · Cited by 46
A Refined Reaction-Diffusion Model of Tau-Microtubule Dynamics and Its Application in FDAP Analysis
Igaev, M., Janning, D., Sündermann, F., Niewidok, B., Brandt, R., & Junge, W. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2014.09.016 · Cited by 44
Tau excess impairs mitosis and kinesin-5 function, leading to aneuploidy and cell death
Bougé, A.-L., & Parmentier, M. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.022558 · Cited by 44
Tau as a potential therapeutic target for ischemic stroke
Chen, X., & Jiang, H. (2019) · Aging · doi:10.18632/aging.102547 · Cited by 45
Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer’s Pathogenesis
Almeida, Z. L., Vaz, D. C., & Brito, R. M. M. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04543-4 · Cited by 49
Misframed ubiquitin and impaired protein quality control: an early event in Alzheimer’s disease
Gentier, R. J. G., & van Leeuwen, F. W. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00047 · Cited by 46
Tau Mislocation in Glucocorticoid-Triggered Hippocampal Pathology
Pinheiro, S., Silva, J. M., Mota, C., Vaz‐Silva, J., Veloso, A., Pinto, V., Sousa, N., Cerqueira, J., & Sotiropoulos, I. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9356-2 · Cited by 47
γ-Aminobutyric Acid Type A (GABAA) Receptor Activation Modulates Tau Phosphorylation
Nykänen, N.-P., Kysenius, K., Sakha, P., Tammela, P., & Huttunen, H. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.309385 · Cited by 43
Links between copper and cholesterol in Alzheimer's disease
Hung, Y. H., Bush, A. I., & Fontaine, S. L. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00111 · Cited by 44
Belrose, J. C., Masoudi, R., Michalski, B., & Fahnestock, M. L. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.08.029 · Cited by 43
Méphon-Gaspard, A., Boca, M., Pioche‐Durieu, C., Desforges, B., Burgo, A., Hamon, L., Piétrement, O., & Pastré, D. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2216-z · Cited by 42
Biofluid Proteomics and Biomarkers in Traumatic Brain Injury
Azar, S., Hasan, A., Younes, R., Najdi, F., Baki, L., Ghazale, H., Kobeissy, F. H., Zibara, K., & Mondello, S. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6952-4_3 · Cited by 43
Carnwath, T., Mohammed, R., & Tsiang, D. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s166322 · Cited by 43
Living with the enemy: from protein-misfolding pathologies we know, to those we want to know
Emwas, A.-H. M., Alghrably, M., Dhahri, M., Sharfalddin, A. A., Alsiary, R., Jaremko, M., Faa, G., Campagna, M., Congiu, T., Piras, M., et al. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101391 · Cited by 43
Parolini, F., Tira, R., Barracchia, C. G., Munari, F., Capaldi, S., D’Onofrio, M., & Assfalg, M. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.12.191 · Cited by 43
Reassignment of consonant allophones in rapid dialect acquisition
German, J. S., Carlson, K., & Pierrehumbert, J. B. (2013) · Journal of Phonetics · doi:10.1016/j.wocn.2013.03.001 · Cited by 42
Arendt, T., Stieler, J., & Holzer, M. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1342-8 · Cited by 46
TTBK2: A Tau Protein Kinase beyond Tau Phosphorylation
Liao, J., Yang, T. T., Weng, R. R., Kuo, C., & Chang, C. (2015) · BioMed Research International · doi:10.1155/2015/575170 · Cited by 42
The structure and phase of tau: from monomer to amyloid filament
Zeng, Y., Yang, J., Zhang, B., Gao, M., Su, Z., & Huang, Y. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03681-x · Cited by 45
Further understanding of tau phosphorylation: implications for therapy
Medina, M., & Avila, J. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1000864 · Cited by 41
Miller, N., Feng, Z., Edens, B. M., Yang, B., Shi, H., Sze, C. C., Hong, B. T., Su, S. C., Cantú, J. A., Topczewski, J., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3716-14.2015 · Cited by 41
Maurin, H., Lechat, B., Dewachter, I., Ris, L., Louis, J. V., Borghgraef, P., Devijver, H., Jaworski, T., & LEUVEN, F. V. (2013) · Molecular Brain · doi:10.1186/1756-6606-6-27 · Cited by 39
Neuronal levels and sequence of tau modulate the power of brain rhythms
Das, M. M., Maeda, S., Hu, B., Yu, G.-Q., Guo, W., Lopez, I., Yu, X., Tai, C., Wang, X., & Mucke, L. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.05.020 · Cited by 42
Self-citationThe Amyloid-Tau-Neuroinflammation Axis in the Context of Cerebral Amyloid Angiopathy
Cisternas, P., Taylor, X., & Lasagna‐Reeves, C. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246319 · Cited by 42
Physiological Tau Interactome in Brain and Its Link to Tauopathies
Šinský, J., Majerová, P., Kováč, A., Kotlyar, M., Jurišica, I., & Hanes, J. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00137 · Cited by 44
Hahn, I., Voelzmann, A., Parkin, J., Fülle, J. B., Slater, P. G., Lowery, L. A., Sánchez‐Soriano, N., & Prokop, A. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009647 · Cited by 45
Temperature and toxic Tau in Alzheimer's disease: new insights
Carrettiero, D. C., Santiago, F. E., Motzko-Soares, A. C. P., & Almeida, M. C. (2015) · Temperature · doi:10.1080/23328940.2015.1096438 · Cited by 41
FRMD4A–cytohesin signaling modulates the cellular release of tau
Yan, X., Nykänen, N.-P., Brunello, C. A., Haapasalo, A., Hiltunen, M. O., Uronen, R., & Huttunen, H. J. (2016) · Journal of Cell Science · doi:10.1242/jcs.180745 · Cited by 43
Ivashko‐Pachima, Y., Maor-Nof, M., & Gozes, I. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213666 · Cited by 40
Cerebrospinal Fluid Brain Injury Biomarkers in Children: A Multicenter Study
Shahim, P., Darín, N., Andréasson, U., Blennow, K., Jennions, E., Lundgren, J., Månsson, J., Naess, K., Törnhage, C., Zetterberg, H., et al. (2013) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2013.02.015 · Cited by 40
Montigny, A. D., Elhiri, I., Allyson, J., Cyr, M., & Massicotte, G. (2013) · Neural Plasticity · doi:10.1155/2013/261593 · Cited by 41
Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy
Gozes, I., Gold, Lorenzl, Stewart, A. J., Morimoto, B. H., & Williams (2012) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s12518 · Cited by 40
Xu, A., Yang, Y., Sun, Y., & Zhang, C. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.241471 · Cited by 39
Magnetic Resonance Imaging and Modeling of the Glymphatic System
Kaur, J., Davoodi‐Bojd, E., Fahmy, L. M., Zhang, L., Ding, G., Hu, J., Zhang, Z., Chopp, M., & Jiang, Q. (2020) · Diagnostics · doi:10.3390/diagnostics10060344 · Cited by 40
Xu, J., Ni, B., Ma, C., Rong, S., Gao, H. Y., Zhang, L., Xia, X., Huang, Q., Deng, Q., & Huang, F. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2022.04.015 · Cited by 39
Mutant human APP exacerbates pathology in a mouse model of NPC and its reversal by a β-cyclodextrin
Maulik, M., Ghoshal, B., Kim, J., Wang, Y., Yang, J., Westaway, D. A., & Kar, S. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds322 · Cited by 39
Shi, C., Zeng, J. Y., Li, Z., Chen, Q., Hang, W., Xia, L., Wu, Y., Chen, J., & Shi, A. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00005 · Cited by 37
O-GlcNAcylation and neuronal energy status: Implications for Alzheimer’s disease
Pinho, T. S., Verde, D. V., Correia, S. C., Cardoso, S., & Moreira, P. I. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.05.003 · Cited by 41
Targeting neurodegeneration to prevent post-traumatic epilepsy.
Ali, I., Silva, J. C., Liu, S., Shultz, S. R., Kwan, P., Jones, N. C., & O'Brien, T. J. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.08.006 · Cited by 38
Increased Tau Expression Correlates with Neuronal Maturation in the Developing Human Cerebral Cortex
Fiock, K. L., Smalley, M. E., Crary, J. F., Pașca, A. M., & Hefti, M. M. (2020) · eNeuro · doi:10.1523/eneuro.0058-20.2020 · Cited by 41
Beyond Neuronal Microtubule Stabilization: MAP6 and CRMPS, Two Converging Stories
Cuveillier, C., Boulan, B., Ravanello, C., Denarier, É., Deloulme, J., Gory‐Fauré, S., Delphin, C., Bosc, C., Arnal, I., & Andrieux, A. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.665693 · Cited by 41
Hori, T., Eguchi, K., Wang, H.-Y., Miyasaka, T., Guillaud, L., Taoufiq, Z., Mahapatra, S., Yamada, H., Takei, K., & Takahashi, T. (2022) · eLife · doi:10.7554/elife.73542 · Cited by 34
Dickinson, M., & Dickinson, D. A. G. (2014) · Studies in Higher Education · doi:10.1080/03075079.2014.912625 · Cited by 39
Wang, X., Smith, K. D. B., Pearson, M. S., Hughes, A. C., Cosden, M. L., Marcus, J., Hess, J. F., Savage, M. J., Rosahl, T. W., Smith, S. M., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195486 · Cited by 35
Yang, T., Tran, K. C., Zeng, A. Y., Massa, S. M., & Longo, F. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-77210-y · Cited by 40
Prifti, E., Tsakiri, E. N., Vourkou, E., Stamatakis, G. M., Samiotaki, M. K., & Papanikolopoulou, K. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1920-20.2020 · Cited by 39
Xu, L., Zheng, J., Margittai, M., Nussinov, R., & Ma, B. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00294 · Cited by 37
Koveal, D., Schuh-Nuhfer, N., Ritt, D., Page, R., Morrison, D. K., & Peti, W. (2012) · Science Signaling · doi:10.1126/scisignal.2003289 · Cited by 36
A Conserved Function in Phosphatidylinositol Metabolism for Mammalian Vps13 Family Proteins
Park, J.-S., Halegoua, S., Kishida, S., & Neiman, A. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124836 · Cited by 36
Stielow, B., Zhou, Y., Cao, Y., Simon, C., Pogoda, H., Jiang, J., Ren, Y., Phanor, S. K., Rohner, I., Nist, A., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf2229 · Cited by 36
Eteläinen, T. S., Silva, M. C., Uhari-Väänänen, J. K., Lorenzo, F. D., Jäntti, M. H., Cui, H., Chavero‐Pieres, M., Kilpeläinen, T. P., Mechtler, C., Svarcbahs, R., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abq2915 · Cited by 36
Bip Enhanced the Association of GSK-3β with Tau During ER Stress Both in vivo and in vitro
Liu, Z.-C., Fu, Z., Song, J., Zhang, J. Y., Wei, Y., Chu, J., Han, L., Qu, N., Wang, J., & Tian, Q. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111898 · Cited by 36
Expression of neurodegenerative disease‐related proteins and caspase‐3 in glioneuronal tumours
Prabowo, A. S., Iyer, A. M., Veersema, T. J., Anink, J. J., Meeteren, A. Y. N. S., Spliet, W. G. M., van Rijen, P. C., Ferrier, C. H., Thom, M., & Aronica, E. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12143 · Cited by 36
Haque, M. M., Kim, D., Yu, Y. H., Lim, S., Kim, D. J., Chang, Y., Ha, H., & Kim, Y. K. (2014) · Amyloid · doi:10.3109/13506129.2014.929103 · Cited by 37
Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms
Hwang, K., Vaknalli, R. N., Addo-Osafo, K., Vicente, M., & Vossel, K. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.903973 · Cited by 35
Self-citationGriffioen, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713243 · Cited by 36
Hristodorov, D., Mladenov, R. D., Pardo, A., Pham, A.-T., Hühn, M., Fischer, R., Thepen, T., & Barth, S. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.457 · Cited by 35
Nguyen, T. V., Hayes, M. I., Zbesko, J. C., Frye, J. B., Congrove, N. R., Belichenko, N. P., McKay, B. S., Longo, F. M., & Doyle, K. P. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0603-4 · Cited by 34
Tau, S100B and NSE as Blood Biomarkers in Acute Cerebrovascular Events
Onatsu, J., Vanninen, R. L., Jäkälä, P., Mustonen, P. E., Pulkki, K. J., Korhonen, M., Hedman, M., Höglund, K., Blennow, K., Zetterberg, H., et al. (2020) · In Vivo · doi:10.21873/invivo.12075 · Cited by 35
Role of the endolysosomal pathway and exosome release in tau propagation
Yan, M., & Zheng, T. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.104988 · Cited by 36
NUB1 modulation of GSK3β reduces tau aggregation
Richet, E., Pooler, A. M., Rodriguez, T., Novoselov, S. S., Schmidtke, G., Groettrup, M., Hanger, D. P., Cheetham, M. E., & van der Spuy, J. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds376 · Cited by 35
Low Serum Insulin-Like Growth Factor-I Predicts Cognitive Decline in Alzheimer’s Disease
Vidal, J., Hanon, O., Funalot, B., Brunel, N., Viollet, C., Rigaud, A., Seux, M., Bouc, Y. L., Epelbaum, J., & Duron, E. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151162 · Cited by 36
Takach, O. P., Gill, T. B., & Silverman, M. A. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.11.018 · Cited by 34
Metadata
- Authors
- Morris, M., Maeda, S., Vossel, K., & Mucke, L.
- Affiliations
- Gladstone Institutes (US)
- Corresponding author
- Mucke, Lennart
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2011-05
- Volume
- 70
- Issue
- 3
- Pages
- 410-426
- ISSN
- 0896-6273 (ISSN-L)
- PMC
- PMC3319390
- OpenAlex
- W2125985978
- Cited by
- 899
- References
- 196
- Citations by year
- 2026: 29 · 2025: 33 · 2024: 36 · 2023: 52 · 2022: 59 · 2021: 65 · 2020: 59 · 2019: 59 · 2018: 72 · 2017: 65 · 2016: 67 · 2015: 70 · 2014: 67 · 2013: 80 · 2012: 59
- FWCI
- 7.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 808 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Neuron (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (AG011385, NS041787)
- Tau Consortium
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- tau protein, microtubule binding, cytoskeletal organization, signaling, neurodegenerative diseases, tauopathy
- MeSH terms
- Animals, Humans, Microtubules, Models, Biological, Signal Transduction, tau Proteins, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
